Lazard Medical Devices, Diagnostics and Tools Leaders Study 2023

This document is a research report detailing the findings of the Lazard Medical Devices, Diagnostics and Tools Leaders Study conducted in April and May 2023. The study involved 145 leaders from the medical devices, diagnostics, and tools industry, including corporate executives and investors. The report outlines the current challenges and transformations within the industry, driven by technological innovations and the need for affordability. Key findings indicate that equity market conditions are not expected to recover to normalized levels before 2024, with a mixed outlook on access to capital and new company formation. The report highlights the anticipated impact of artificial intelligence, robotics, and data analytics on device design and manufacturing. It also discusses the expected growth in partnerships and collaborations, as well as the importance of an improved macroeconomic outlook for market recovery. The document presents insights into the future landscape of the industry over the next five to ten years, emphasizing the role of innovation and strategic activity.